On December 13, 2023, Twin Health, Inc. closed the transaction. The company has issued 6,137,436 series D preferred shares for gross proceeds of $50,000,003.2971 in the transaction. The round of funding led by new investor, Temasek Holdings (Private) Limited.

The transaction included participation from returning investors, Peak XV Partners, Sofina Société Anonyme, ICONIQ Growth and Helena Group Foundation.